Preventing substance misuse: study protocol for a randomised controlled trial of the Strengthening Families Programme 10-14 UK (SFP 10-14 UK)
Jeremy Segrott, David Gillespie, Jo Holliday, Ioan Humphreys, Simon Murphy, Ceri Phillips, Hayley Reed, Heather Rothwell, David Foxcroft, Kerenza Hood, Zoe Roberts, Jonathan Scourfield, Claire Thomas, Laurence Moore
BMC Public Health | BMC | Published : 2014
Awarded by Economic and Social Research Council
Awarded by Wellcome Trust
Awarded by Medical Research Council
Awarded by Chief Scientist Office
Funding of 2.1 pound M from the National Prevention Research Initiative, managed by the Medical Research Council, includes c.650 pound k implementation costs. The NPRI funding partners are Alzheimer's Research Trust; Alzheimer's Society; Biotechnology and Biological Sciences Research Council; British Heart Foundation; Cancer Research UK; Chief Scientist Office, Scottish Government Health Directorate; Department of Health; Diabetes UK; Economic and Social Research Council; Engineering and Physical Sciences Research Council; Health & Social Care Research & Development Office for Northern Ireland; Medical Research Council; The Stroke Association; Welsh Government; and World Cancer Research Fund.A representative from the study funders is a member of the trial's Independent Trial Steering Committee. The Welsh Government provided c. 675 pound k of partnership funding, to cover the cost of implementation in three trial areas, and the associated training and support provided by the Cardiff Strengthening Families Programme team. Further support from Welsh Government provided 208 pound k to cover programme delivery in six trial sites from August 2011-July 2012. The Cardiff Strengthening Families Programme team also provided financial support for programme delivery and trial recruitment in schools.DECIPHer is a UKCRC Public Health Research Centre of Excellence. Funding from the British Heart Foundation, Cancer Research UK, Economic and Social Research Council (RES-590-28-0005), Medical Research Council, the Welsh Government and the Wellcome Trust (WT087640MA), under the auspices of the UK Clinical Research Collaboration, is gratefully acknowledged. DECIPHer funding has supported JSe and JH's input into the trial.The South East Wales Trial Unit is funded by the National Institute for Health and Social Care Research (NISCHR).